Tony Gershlick

Gershlick was born in 1951, in Southend, England. He suffered from dyslexia and described himself as a poor student in his early years, before finding success in medical school at St Mary's Hospital, London.[2] He earned his Bachelors of Science in 1973 in biochemistry, followed by a MBBS in 1976, and the qualifications of MRCP in 1980.[3]

Gershlick worked as an interventional cardiologist at Glenfield Hospital for more than 30 years.[1] He was the UK lead for more than 10 international clinical trials and was an active researcher of cardiovascular procedures.[4]

Gershlick was the first doctor in the UK to insert a drug-eluting stent into a patient, which is now considered the standard of practice.[5] During his career, he served on the councils of the British Cardiovascular Intervention Society, British Cardiovascular Society, and European Society of Cardiology.[3]

In January 2017, he was awarded the British Cardiovascular Intervention Society Lifetime Achievement Career Award. He was elected as a fellow of the Royal College of Physicians in 1994.[3]

Amid the COVID-19 pandemic in the United Kingdom, Gershlick died from COVID-19 in the intensive care unit of the hospital he had worked at for most of his career. He was 69 years old.